Search | Clinical Trials Finder

ClinicalTrials.gov public records Last synced Sep 22, 2026, 3:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–40 of 16 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Intervention: Placebo-CPAP Clear all

Conditions: Diabetes, Sleep Apnea
Interventions: CPAP mask, Placebo; Device · Drug
Lead sponsor: University of Chicago; Other
Eligibility: 45 Years to 75 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Obstructive Sleep Apnea, OSA, Sleep Apnea
Interventions: Dimethyl fumarate, Placebo; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 65 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Obstructive Sleep Apnea of Adult
Interventions: Atorvastatin 10mg, Placebo; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Obstructive Sleep Apnea, Nasal Congestion, Sinus Congestion
Interventions: Thermosmart & placebo, Placebo Device & Nasacort, Placebo Arm; Drug · Device
Lead sponsor: Clayton Sleep Insititute; Industry
Eligibility: 16 Years to 65 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Lung Diseases, Sleep Apnea Syndromes, Sleep
Interventions: Active CPAP, Sham CPAP; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 1,105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2008
U.S. locations: 5
States / cities: Tucson, Arizona • Palo Alto, California • Boston, Massachusetts + 2 more

Conditions: Obstructive Sleep Apnea
Interventions: Eszopiclone, Placebo control; Drug
Lead sponsor: Walter Reed Army Medical Center; Federal
Eligibility: 18 Years to 64 Years
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Organic Pediatric Obstructive Sleep Apnea
Interventions: Nasal Expiratory Positive Airway Pressure Device, placebo sham; Device
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 5 Years to 16 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: OSA, Sleep Apnea, Obstructive Sleep Apnea, Alzheimer Disease
Interventions: Supplemental Oxygen, Continuous Positive Airway Pressure Machine, Room Air; Other · Device
Lead sponsor: University of California, San Diego; Other
Eligibility: 65 Years to 85 Years
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Lung Diseases, Sleep Apnea Syndromes, Hypertension
Interventions: Continuous Positive Airway Pressure (CPAP) Treatment, Sham CPAP device - CPAP device with pressure delivered <1 cm H20; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 100 Years
Enrollment: 281 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 4
States / cities: Denver, Colorado • Atlanta, Georgia • Long Island City, New York + 1 more

Conditions: Epilepsy, Sleep Apnea, Obstructive Sleep Apnea
Interventions: continuous positive airway pressure (CPAP), Placebo-CPAP; Device
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2008
U.S. locations: 4
States / cities: Ann Arbor, Michigan • Chapel Hill, North Carolina • Cleveland, Ohio + 1 more

Conditions: Polycystic Ovary Syndrome, Obstructive Sleep Apnea
Interventions: continuous positive airway pressure (CPAP), depot leuprolide plus estrogen/progestin replacement, pioglitazone, REM frag, SWS supp; Device · Drug · Procedure
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 40 Years
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2008
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Sleep Apnea, Obstructive
Interventions: Modafinil; Drug
Lead sponsor: Cephalon; Industry
Eligibility: 6 Years to 16 Years
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2005
U.S. locations: 60
States / cities: Birmingham, Alabama • Tucson, Arizona • Fort Smith, Arkansas + 51 more

Conditions: Sleep Apnea, Sleep Apnea, Obstructive
Interventions: Oxytocin, Placebo; Drug
Lead sponsor: Vivek Jain; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Obstructive Sleep Apnea
Interventions: PAP therapy, Sham PAP therapy; Device
Lead sponsor: University of Tennessee; Other
Eligibility: 6 Years to 12 Years
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Obstructive Sleep Apnea
Interventions: Propranolol Oral Tablet, Placebo Oral Tablet; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 20 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Obstructive Sleep Apnea
Interventions: Lunesta, Placebo control; Drug
Lead sponsor: Walter Reed Army Medical Center; Federal
Eligibility: 18 Years to 64 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Search by objective public record fields.

Effective Treatment of Sleep Apnea in Prediabetes to Reduce Cardiometabolic Risk

Dimethyl Fumarate for Obstructive Sleep Apnea

Endothelial Function in Obstructive Sleep Apnea

Effect of Heated Humidity With Thermosmart™ Compared to an Intranasal Steroid in Improving Compliance and Nasal Symptoms in Patients Using Continuous Positive Airway Pressure

Apnea Positive Pressure Long-Term Efficacy Study

Continuous Positive Airway Pressure (CPAP) Promotion And Prognosis - the Army Sleep Apnea Program (ASAP)

Nasal Expiratory Positive Airway Pressure for the Treatment of Pediatric Obstructive Sleep Apnea Syndrome

Is Obstructive Sleep Apnea Important in the Development of Alzheimer's Disease?

Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep Apnea

Effects of Treating Obstructive Sleep Apnea in Epilepsy

Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome

Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) Machine

Effects of Positive Airway Pressure (PAP) in Children With Obstructive Sleep Apnea (OSA)

Propranolol for Sleep Apnea Therapy

Ezopiclone Improves the Quality of Overnight Polysomnography